CLINICAL TRIALS PROFILE FOR DEFLAZACORT
✉ Email this page to a colleague
All Clinical Trials for DEFLAZACORT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00243789 ↗ | Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy | Completed | Cooperative International Neuromuscular Research Group | Phase 1/Phase 2 | 2005-09-01 | The purpose of this study is to see if male children with Duchenne muscular dystrophy (DMD) have changes in strength when given the drug Pentoxifylline as a rescue treatment. A total of 64 subjects are expected to participate through all other centers of the Cooperative International Neuromuscular Research Group (CINRG) worldwide. The primary purpose of this study is to see whether the addition of pentoxifylline to a steroid regimen is effective in treating deteriorating muscle strength by comparing the muscle strength of PTX treated subjects and placebo treated subjects. |
| NCT00527228 ↗ | Deflazacort in Dysferlinopathies | Completed | Ludwig-Maximilians - University of Munich | Phase 2/Phase 3 | 2003-09-01 | The present study is designed to assess the natural history in a one year pre-phase of the trial and evaluate therapeutic efficacy and side effects of deflazacort in LGMD2B/MM patients in a placebo-controlled trial. Furthermore, long-term development of the disease under naturalistic conditions will be documented in a 2-year follow-up after the end of the double-blind treatment phase. |
| NCT01335295 ↗ | Safety Study of Flavocoxid in Duchenne Muscular Dystrophy | Completed | University of Messina | Phase 1 | 2011-03-01 | Objective of this study is to evaluate safety and tolerability of flavocoxid administered at the daily oral dose of 500 or 1000 mg/die for one year in DMD patients, alone or in association with steroids (deflazacort on alternate days) started at least one year before. The investigators will also perform a multidimensional clinical evaluation covering functional and muscle strength and quality of life (QoL)assessments. |
| NCT01603407 ↗ | Finding the Optimum Regimen for Duchenne Muscular Dystrophy | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 | 2013-01-01 | The Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR DMD) study will compare three ways of giving corticosteroids to boys with Duchenne muscular dystrophy (DMD) to determine which of the three ways increases muscle strength the most, and which causes the fewest side effects. Using the results of this study, the investigators aim to provide patients and families with clearer information about the best way to take these drugs. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEFLAZACORT
Condition Name
Clinical Trial Locations for DEFLAZACORT
Trials by Country
Clinical Trial Progress for DEFLAZACORT
Clinical Trial Phase
Clinical Trial Sponsors for DEFLAZACORT
Sponsor Name
